Desjardins Global Asset Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Desjardins Global Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$98.98 - $115.74 $82,252 - $96,179	831 New	831 $96,000
Q1 2023 May 01, 2023	SELL	$107.32 - $113.5 $52,479 - $55,501	-489 Reduced 18.71%	2,124 $232,000
Q4 2022 Feb 08, 2023	BUY	$62.39 - $113.8 $11,542 - $21,053	185 Added 7.62%	2,613 $297,000
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $192,783 - $282,522	2,428 New	2,428 $193,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Desjardins Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Desjardins Global Asset Management Inc. with notifications on news.